Cargando…
Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics
Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has become a worldwide pandemic. Symptoms range from mild fever to cough, fatigue, severe pneumonia, acute respiratory distress syndrome (ARDS), and organ failure, with a mortality rate of 2.2%. However, there are no licensed drugs...
Autores principales: | Choi, Hyung Muk, Moon, Soo Youn, Yang, Hyung In, Kim, Kyoung Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915126/ https://www.ncbi.nlm.nih.gov/pubmed/33572274 http://dx.doi.org/10.3390/ijms22041737 |
Ejemplares similares
-
Dysregulated Autophagy Mediates Sarcopenic Obesity and Its Complications via AMPK and PGC1α Signaling Pathways: Potential Involvement of Gut Dysbiosis as a Pathological Link
por: Ryu, Ji Yeon, et al.
Publicado: (2020) -
Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases
por: Choi, Hyung Muk, et al.
Publicado: (2020) -
A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea
por: Choi, Rihwa, et al.
Publicado: (2019) -
Understanding the mechanisms of viral induced asthma: New therapeutic directions
por: Hansbro, Nicole G., et al.
Publicado: (2008) -
Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19
por: Bae, Seongman, et al.
Publicado: (2021)